AngioDynamics designs, manufactures and sells medical, surgical and diagnostic devices for the treatment of peripheral vascular disease, vascular access and for use in oncology and surgical settings. The company's business units are: Oncology/Surgery, which provides a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the NanoKnife System; Vascular Interventions and Therapies, which supports the medical areas of venous insufficiency, thrombus management, and peripheral products; and Vascular Access, which includes peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters and related accessories and supplies.

Eton Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products utilizing the FDA's 505(b)(2) regulatory pathway. The company's product candidates focuses on liquid formulation, including injectables, oral liquids, and ophthalmics. The company's formula products include: EM-100, an ophthalmic solution indicated for the treatment of allergic conjunctivitis; ET-202, an injectable product candidate to be used in the hospital setting; ET-103, an oral liquid formulation of levothyroxine for the treatment of hypothyroidism; and ET-203, an injectable product candidate to be used in the hospital setting.

Paycom Software is a provider of cloud-based human capital management (HCM) solution delivered as Software-as- a-Service. The company provides functionality and data analytics that businesses need to manage the complete employment lifecycle, from recruitment to retirement. The company's solution requires virtually no customization and is based on a core system of record maintained in a single database for various HCM functions, including talent acquisition, time and labor management, payroll, talent management and human resources management applications. The company's solution was developed in-house and is based on a single platform, there is no need to integrate, update or access various databases.

Tile Shop Holdings is a holding company. Through its subsidiaries, the company is a retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the U.S. The company provides a range of natural stone and man-made tile products, sourced directly from its suppliers. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, and metal tiles. The company's accessories, including trim pieces, mosaics, pencils, listellos, and other products. The company also provides a range of setting and maintenance materials, such as thinset, grout, sealers, and accessories.

X4 Pharmaceuticals is a clinical-stage biopharmaceutical company focused on applying monoclonal antibody (mAb) immunotherapies to address serious infectious diseases. The company's Programs: ASN100 is a combination of two fully human mAbs that are co-administered intravenously to neutralize the six cytotoxins critical to S. aureus pneumonia pathogenesis; ASN500 is a mAb targeting respiratory syncytial virus, a virus that can cause serious respiratory tract infections in young children and elderly and immunocompromised patients; and the company's preclinical stage Gram-negative mAb programs, ASN300 for Klebsiella pneumoniae and ASN200 for Escherichia coli, were outlicensed to the company's subsidiary.